HuMiX, the Human-Microbe Crosstalk Device
An in vitro Microbiome-Based Tool for the Investigation of the Human-Microbiome interaction
Published: 23rd March 2021

Patents
- Patent “microfluidic in vitro model for elucidating the molecular effects of simulated dietary regimens on gut microbiota and host cells” (Appl. No EP19802182.6, published as EP3880795A1; Appl. No US17/294,587, published as US 2022/0002655)
- Owned by the University of Luxembourg and filed in 2018
- European Patent Office approval: pending
- United States Patent and Trademark Office approval: pending
IP Status
- Patent application submitted
- Know-how based